The preventive effect of Pentazocine on urinary catheter-related bladder discomfort after general anesthesia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800016388

Enrollment

Unknown

Registered

2018-05-29

Start date

2018-06-10

Completion date

Unknown

Last updated

2018-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor

Interventions

Pentazocine group:Pentazocine analgesia

control group:Use physiological saline

Eligibility

Sex/Gender

Male

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. the male patients who need to retain the catheter under general anesthesia; 2. aged 20-70 years old; 3. body mass index (18~25 kg. M-2); 4. ASA grade I or grade II; 5. no serious cardiovascular disease.

Exclusion criteria

Exclusion criteria: 1. heart, liver and kidney dysfunction; 2. central nervous system diseases; 3. urinary system diseases; 4. opiate medication history.

Design outcomes

Primary

Measure	Time frame
Incidence of CRBD;	—

Countries

China

Contacts

Public ContactJuan Li

huamuzi1999@126.com+86 13956005465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026